PCN161 COST-EFFECTIVENESS OF FOLFIRI + CETUXIMAB VS....

PCN161 COST-EFFECTIVENESS OF FOLFIRI + CETUXIMAB VS. FOLFIRI + BEVACIZUMAB IN FIRST-LINE TREATMENT OF RAS WILD-TYPE (WT) METASTATIC COLORECTAL CANCER WITH LEFT-SIDED PRIMARY TUMOUR LOCATION IN ITALY: A COUNTRY ADAPTATION BASED ON THE FIRE-3 TRIAL

van Oostrum, I., Bruno, G.M., Novelli, P., Pescott, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.357
Date:
November, 2019
File:
PDF, 322 KB
2019
Conversion to is in progress
Conversion to is failed